Your browser doesn't support javascript.
loading
Immunological and classical subtypes of oral premalignant lesions.
Foy, Jean-Philippe; Bertolus, Chloé; Ortiz-Cuaran, Sandra; Albaret, Marie-Alexandra; Williams, William N; Lang, Wenhua; Destandau, Solène; Souza, Geneviève De; Sohier, Emilie; Kielbassa, Janice; Thomas, Emilie; Deneuve, Sophie; Goudot, Patrick; Puisieux, Alain; Viari, Alain; Mao, Li; Caux, Christophe; Lippman, S M; Saintigny, P.
Afiliação
  • Foy JP; Univ Lyon, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.
  • Bertolus C; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Ortiz-Cuaran S; Department of Oral and Maxillofacial Surgery, University of Pierre Marie Curie-Paris 6, Hôpital Pitié-Salpêtrière, Paris, France.
  • Albaret MA; Department of Oral and Maxillofacial Surgery, University of Pierre Marie Curie-Paris 6, Hôpital Pitié-Salpêtrière, Paris, France.
  • Williams WN; Univ Lyon, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.
  • Lang W; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Destandau S; Univ Lyon, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.
  • Souza G; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Sohier E; MD Anderson Cancer Center, Thoracic/Head and Neck Medical Oncology at the University of Texas M. D., Houston, TX, USA.
  • Kielbassa J; MD Anderson Cancer Center, Thoracic/Head and Neck Medical Oncology at the University of Texas M. D., Houston, TX, USA.
  • Thomas E; Univ Lyon, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.
  • Deneuve S; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Goudot P; Univ Lyon, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.
  • Puisieux A; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Viari A; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Mao L; Synergie Lyon Cancer-Platform of Bioinformatics Gilles Thomas, Lyon, France.
  • Caux C; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Lippman SM; Synergie Lyon Cancer-Platform of Bioinformatics Gilles Thomas, Lyon, France.
  • Saintigny P; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
Oncoimmunology ; 7(12): e1496880, 2018.
Article em En | MEDLINE | ID: mdl-30524889
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article